TASE Ends Sunday Mixed, Though Telco Shares Plunge

EU approval of drug for treating chemotherapy side-effects lifts Teva by just under 3%

Tel Aviv shares finished mixed on Sunday, with Teva Pharmaceuticals and Israel Chemicals ending strongly higher while technology...